» Articles » PMID: 22407430

Consistency Between Cross-sectional and Longitudinal SNP: Blood Lipid Associations

Overview
Journal Eur J Epidemiol
Specialty Public Health
Date 2012 Mar 13
PMID 22407430
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Various studies have linked different genetic single nucleotide polymorphisms (SNPs) to different blood lipids (BL), but whether these "connections" were identified using cross-sectional or longitudinal (i.e., changes over time) designs has received little attention. Cross-sectional and longitudinal assessments of BL [total, high-, low-density lipoprotein cholesterol (TC, HDL, LDL), triglycerides (TG)] and non-genetic factors (body mass index, smoking, alcohol intake) were measured for 2,002 Geneva, Switzerland, adults during 1999-2008 (two measurements, median 6 years apart), and 20 SNPs in 13 BL metabolism-related genes. Fixed and mixed effects repeated measures linear regression models, respectively, were employed to identify cross-sectional and longitudinal SNP:BL associations among the 1,516 (76%) study participants who reported not being treated for hypercholesterolemia at either measurement time. One-third more (12 vs. 9) longitudinal than cross-sectional associations were found [Bonferroni-adjusted two-tailed p < 0.00125 (=0.05/2)/20) for each of the four ensembles of 20 SNP:individual BL associations tested under the two study designs]. There was moderate consistency between the cross-sectional and longitudinal findings, with eight SNP:BL associations consistently identified across both study designs: [APOE.2 and APOE.4 (rs7412 and rs429358)]:TC; HL/LIPC (rs2070895):HDL; [APOB (rs1367117), APOE.2 and APOE.4 (rs7412 and rs429358)]:LDL; [APOA5 (rs2072560) and APOC III (rs5128)]:TG. The results suggest that cross-sectional studies, which include most genome-wide association studies (GWAS), can assess the large majority of SNP:BL associations. In the present analysis, which was much less powered than a GWAS, the cross-sectional study was around 2/3 (67%) as efficient as the longitudinal study.

Citing Articles

SPA: effectively controlling for sample relatedness in large-scale genome-wide association studies of longitudinal traits.

Xu H, Ma Y, Xu L, Li Y, Liu Y, Li Y Nat Commun. 2025; 16(1):1413.

PMID: 39915470 PMC: 11803118. DOI: 10.1038/s41467-025-56669-1.


Association of Genetically Predicted BCAA Levels with Muscle Fiber Size in Athletes Consuming Protein.

Hall E, Semenova E, Bondareva E, Andryushchenko L, Larin A, Cieszczyk P Genes (Basel). 2022; 13(3).

PMID: 35327951 PMC: 8955300. DOI: 10.3390/genes13030397.


Lack of association between genetic variants in the 19q13.32 region and CHD risk in the Algerian population: a population-based nested case-control study.

Boulenouar H, Hetraf S, Djellouli H, Meroufel D, Fodil F, Hammani-Medjaoui I Afr Health Sci. 2020; 20(2):735-744.

PMID: 33163038 PMC: 7609110. DOI: 10.4314/ahs.v20i2.25.


Genome-wide Association Study of Change in Fasting Glucose over time in 13,807 non-diabetic European Ancestry Individuals.

Liu C, Merino J, Rybin D, DiCorpo D, Benke K, Bragg-Gresham J Sci Rep. 2019; 9(1):9439.

PMID: 31263163 PMC: 6602949. DOI: 10.1038/s41598-019-45823-7.


Whole Genome Sequence, Variant Discovery and Annotation in Mapuche-Huilliche Native South Americans.

Vidal E, Moyano T, Bustos B, Perez-Palma E, Moraga C, Riveras E Sci Rep. 2019; 9(1):2132.

PMID: 30765821 PMC: 6376018. DOI: 10.1038/s41598-019-39391-z.


References
1.
Kathiresan S, Willer C, Peloso G, Demissie S, Musunuru K, Schadt E . Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2008; 41(1):56-65. PMC: 2881676. DOI: 10.1038/ng.291. View

2.
Bauerfeind A, Knoblauch H, Costanza M, Luganskaja T, Toliat M, Nurnberg P . Concordant association of lipid gene variation with a combined HDL/LDL-cholesterol phenotype in two European populations. Hum Hered. 2006; 61(3):123-31. DOI: 10.1159/000093773. View

3.
Morabia A, Cayanis E, Costanza M, Ross B, Flaherty M, Alvin G . Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors. Hum Mol Genet. 2003; 12(21):2733-43. DOI: 10.1093/hmg/ddg314. View

4.
Aulchenko Y, Ripatti S, Lindqvist I, Boomsma D, Heid I, Pramstaller P . Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 2008; 41(1):47-55. PMC: 2687074. DOI: 10.1038/ng.269. View

5.
Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F . Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res. 2003; 44(12):2374-81. DOI: 10.1194/jlr.M300253-JLR200. View